目錄:愛必信(上海)生物科技有限公司>>生化試劑>>小分子化合物>> abs47028211Bovinocidin 504-88-1
| 參考價 | ¥560-¥1100 |
參考價:¥560 ~ ¥1100
100mg 500mg
CAS:504-88-1 純度:≥98% 分子量:119.08 分子式:C3H5NO4 供貨周期:現(xiàn)貨 規(guī)格:100mg 貨號:abs47028211 應(yīng)用領(lǐng)域:化工,生物產(chǎn)業(yè),農(nóng)林牧漁,制藥/生物制藥,綜合 主要用途:is an irreversible inhibitor of succinat
>| 100mg | 560元 | 999mg可售 |
| 500mg | 1100元 | 999mg可售 |
更新時間:2026-01-23 13:33:17瀏覽次數(shù):670評價
聯(lián)系我們時請說明是化工儀器網(wǎng)上看到的信息,謝謝!
| CAS | 504-88-1 | 純度 | ≥98% |
|---|---|---|---|
| 分子量 | 119.08 | 分子式 | C3H5NO4 |
| 供貨周期 | 現(xiàn)貨 | 規(guī)格 | 100mg |
| 貨號 | abs47028211 | 應(yīng)用領(lǐng)域 | 化工,生物產(chǎn)業(yè),農(nóng)林牧漁,制藥/生物制藥,綜合 |
| 主要用途 | is an irreversible inhibitor of succinat |
Bovinocidin 504-88-1
| 產(chǎn)品描述 | |
| 描述 | Bovinocidin is an irreversible inhibitor of succinate dehydrogenase. |
| 純度 | ≥98% |
| 儲存/保存方法 | Store at -20℃ for one year(Powder);Store at 2-4℃ for two weeks;Store at -20℃ for six months after dissolution. |
| 基本信息 | |
| 別名 | 3-硝基丙酸; 3-Nitropropanoic acid;β-Nitropropionic acid |
| 外觀 | white to light yellow powder |
| 可溶性/溶解性 | DMSO : 125 mg/mL (1049.71 mM; Need ultrasonic) H2O : 100 mg/mL (839.77 mM; Need ultrasonic) |
| 生物活性 | |
| 靶點 | Succinate dehydrogenase |
| In vitro(體外研究) | 3-nitropropionic acid (3-NPA) is an irreversible inhibitor of complex II in the mitochondria. It impairs cellular energy metabolism via inhibition of succinate dehydrogenase, which induces a reduction in ATP production and leads to oxidative stress. 3-NPA can cause the generation and release of ROS from mitochondria, mitochondrial DNA damage, and thus loss of mitochondrial function. 3-NPA reduces the number of large follicles, impairs oocyte development, and increases the percentage of atretic large follicles and ROS levels in oocytes and granulosa cells. ROS production followed by mitochondrial DNA damage is the primary event in 3-NPA toxicity, and Bcl-2 protects PC12 cells from 3-NPA toxicity by preventing mitochondrial DNA damage. |
| In vivo(體內(nèi)研究) | 3-NPA induces granulosa cell apoptosis, large follicle atresia, and an increase of ROS levels in the ovary. |
| 研究領(lǐng)域 | |
| 研究領(lǐng)域 | Metabolism MetabolismTypes of disease Drug DiscoverySmall Molecule DrugLead Compound Discovery |
(空格分隔,最多3個,單個標(biāo)簽最多10個字符)